Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-r...
Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steu...
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )
10 Apr 2019
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) (  )
9 Apr 2019
Ethics of cancer care: Beyond biology and medicine
Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
Ethics of cancer care: Beyond biology and medicine ( Ms Soumita Ghose - Tata Medical Centre, Kolkata, India )
28 Mar 2019
Regional radiation benefits high risk breast cancer patients
Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK
Regional radiation benefits high risk breast cancer patients ( Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK )
14 Dec 2018
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from th...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )
14 Dec 2018
Polygenic risk scores for breast cancer: ready or not?
Prof Gareth Evans - University of Manchester, Manchester, UK
Polygenic risk scores for breast cancer: ready or not? ( Prof Gareth Evans - University of Manchester, Manchester, UK )
14 Dec 2018
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA
Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2018
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018
Single cell genomics in breast cancer: breast tumour evolution and intra-tumour ...
Dr Nicholas Navin - MD Anderson Cancer Center, Houston, USA
Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity ( Dr Nicholas Navin -  MD Anderson Cancer Center, Houston, USA )
14 Dec 2018
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA )
14 Dec 2018
Association of pathologic complete response following neoadjuvant chemotherapy w...
Dr Laura Spring - Harvard Medical School, Boston, USA
Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer ( Dr Laura Spring - Harvard Medical School, Boston, USA )
14 Dec 2018
Results from adding adjuvant capecitabine to treatment for breast cancer patient...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
Results from adding adjuvant capecitabine to treatment for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
13 Dec 2018